mumps virus vaccine
Jump to navigation
Jump to search
Introduction
Generally used in combination with other vaccines
Pathology
- no evidence of emergence of resistant genotypes
Management
- a 3rd vaccine dose around 18 years of age, with or without regular dosing in adulthood is suggested
Notes
- vaccine protection seems to last an average of 27 years after the last dose (from mathematical models of outbreaks)
- among people with an immune response to the vaccine, 25% may lose protection by 8 years, 50% by 19 years, & 75% by 38 years (not clear if this is disappearingcirculating IgG or mathematical models of outbreaks)
More general terms
Additional terms
Component of
- measles virus vaccine live attenuated/mumps virus vaccine/rubella virus vaccine live
- measles virus vaccine live attenuated/mumps virus vaccine/rubella virus vaccine live/varicella virus vaccine
References
- ↑ Lewnard JA, Grad YH Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018 Mar 21;10(433) Vol. 10, Issue 433, eaao5945 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29563321 <Internet> http://stm.sciencemag.org/content/10/433/eaao5945